Table 2. Association between miR-29b methylation status and clinicopathologic characteristics of gastric cancer patients.
| Variables | Cases (n=84) | Methylated (n=52) | Unmethylated (n=32) | P value |
|---|---|---|---|---|
| Age (years old) | 0.498 | |||
| ≤65 | 37 | 21 | 16 | |
| ≤65 | 47 | 31 | 16 | |
| Sex | 0.646 | |||
| Male | 51 | 33 | 18 | |
| Female | 33 | 19 | 14 | |
| Tumor differentiation | 0.042* | |||
| Well and Moderate | 45 | 23 | 22 | |
| Poor | 39 | 29 | 10 | |
| Tumor size (cm) | 0.099 | |||
| ≤5 | 56 | 31 | 25 | |
| ≤5 | 28 | 21 | 7 | |
| Lymph node metastasis | 0.014* | |||
| Present | 41 | 31 | 10 | |
| Absent | 43 | 21 | 22 | |
| Distant metastasis | 0.092 | |||
| Present | 16 | 13 | 3 | |
| Absent | 68 | 39 | 29 | |
| TNM stage | 0.004** | |||
| I-II | 43 | 20 | 23 | |
| III-IV | 41 | 32 | 9 |
* P<0.05; ** P<0.01.